BP000183-CYT-386: Recombinant Mouse Fibroblast Growth Factor 2 (FGF2) Protein
Source: E. coli-derived.
The activity as calculated by the dose-dependant proliferation of BALB/3T3 cells was found to be 0.1-0.16 ug/ml.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000189-CYT-620: Recombinant Human Fibroblast growth factor 12 (FGF12) Protein
Source: E. coli-derived.
Purity: > 90% by SDS-PAGE.BP000181-CYT-613: Bovine Fibroblast Growth Factor Acidic (FGF Acidic) Protein
Source: Bovine Brain-derived.
Stimulates growth of bovine capillary endothelial cells by 3-5 fold over 5% calf serum at 10-25 ug/ml FGF and 0 ug/ml heparin.
Purity: > 90%.BP000181-CYT-528: Recombinant Mouse Fibroblast Growth Factor Acidic (FGF Acidic) Protein
Source: E. coli-derived.
The ED50 as determined by the dose-dependent proliferation of mouse BALB/c 3T3 cells, is less than 0.04 ug/ml corresponding to a Specific Activity of 25 MIU/mg.
Purity: > 98% by SDS-PAGE and RP-HPLC.BP000181-CYT-264: Recombinant Human Fibroblast Growth Factor Acidic (FGF Acidic) Protein
Source: E. coli-derived.
The ED50, calculated by the dose-dependant proliferation of mouse BALB/c 3T3 cells is <0.5 ug/ml, corresponding to a specific activity of > 2.0 x 1,000,000 IU/mg.
Purity: > 95% by SDS-PAGE and RP-HPLC.BP000322-PRO-594: Recombinant Human FAS His Tag
Source: E.coli-derived.
Purity> 95%, by SDS-PAGE and RP-HPLC.BP000322-CYT-125: Recombinant Human FAS
Source: E.coli-derived.
The ED50 was determined by its ability to inhibit the cytotoxicity of Jurkat cells is between 10-15 ug/ml in the presence of 2 ug/ml of hFasL.
Purity> 95%, by SDS-PAGE and RP-HPLC.BP000016-PRO-566: Recombinant Human Fatty-acid Binding Protein 4, His Tag (FABP4)
Source: E. coli-derived.
Purity: > 95% by SDS-PAGE.BP000296-CHM-371: Recombinant Mouse Exodus-2 (CCL21)
Source: E. coli-derived.
Determined by its ability to chemoattract total murine T cell population using a concentration range of 10-100 ug/ml corresponding to a Specific Activity of 10,000-100,000 IU/mg.
Purity > 97%, by SDS-PAGE and RP-HPLC.BP000296-CHM-332: Recombinant Human Exodus-2 (CCL21)
Source: E. coli-derived.
Determined by its ability to chemoattract human total lymphocyte population using a concentration range of 10-100 ug/ml.
Purity > 97%, by SDS-PAGE and RP-HPLC.